A Hierarchical Multi-modal AI Framework for Pathological and Genetic Subtyping of Lung Cancer Based on PET/CT Imaging

PET/CT imaging and clinical information (age, gender, smoking history, family history of cancer, history of present illness, and several tumor biomarkers, etc.) were used to establish a hierarchical multi-modal AI framework for pathological and genetic subtyping of lung cancer

NCT Number	NCT07463300
Lead Sponsor	Second Affiliated Hospital, School of Medicine, Zhejiang University Collaborators: First Hospital of China Medical University, West China Hospital, Zhongnan Hospital, Zhejiang Cancer Hospital, Guangdong Second Provincial General Hospital, The First Affiliated Hospital of Zhejiang Chinese Medical University, Wuhan TongJi Hospital, Northern Jiangsu People's Hospital
Conditions	Lung Cancer
Enrollment	5,500 participants
Start Date	2024-08-01
Primary Completion	2027-08-01 (estimated)
Study Completion	2027-08-01 (estimated)
Updated on ClinicalTrials.gov	2026-03-11